Related Experiment Video

Updated: Sep 27, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.6K

Deep Brain Stimulation for a Patient with Familial Parkinson's Disease Harboring CHCHD2 p.T61I

Hikaru Kamo1, Genko Oyama1,2,3,4,5,6, Kenya Nishioka1

  • 1Department of Neurology Juntendo University Graduate School of Medicine Tokyo Japan.

Movement Disorders Clinical Practice
|April 11, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CHCHD2deep brain stimulationfamilial Parkinson's disease

More Related Videos

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

14.9K
Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
09:46

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Published on: March 8, 2015

11.1K

Related Experiment Videos

Last Updated: Sep 27, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.6K
A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

14.9K
Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
09:46

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Published on: March 8, 2015

11.1K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

414
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
414

Articles linked to this work by shared authors, journal, and citation graph.

Perceived problems in movement control at the piano among Japanese conservatory-trained classical pianists: a cross-sectional questionnaire survey screening for musician's dystonia.

Journal of neural transmission (Vienna, Austria : 1996)·2026

PINK1 and PARKIN Deficiency Increases Neuronal Vulnerability to Autoimmune Neuroinflammation Through Mitochondrial Fragmentation in Aged Mice.

Journal of neurochemistry·2026

Tegmental atrophy in isolated REM sleep behaviour disorder: ex vivo MRI-informed in vivo imaging.

Brain communications·2026

Marked intrafamilial phenotypic heterogeneity associated with the CSF1R c.2539G>A pathogenic variant in a Japanese family.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Perlecan regulates exercise-induced PGC-1α isoform expression and angiogenic gene program in skeletal muscle.

American journal of physiology. Cell physiology·2026

How Do Oral Medications, Botulinum Toxin Use, and Treatment Burden Change after Deep Brain Stimulation for Dystonia?

Movement disorders clinical practice·2026

Multidomain Polysomnographic Abnormalities in Cervical Dystonia: REM Suppression, Respiratory Instability, and Sensorimotor Dysregulation.

Movement disorders clinical practice·2026

Intestinal Methanogen Overgrowth in Parkinson's Disease Reflects Constipation Physiology: A Matched Cohort Study.

Movement disorders clinical practice·2026

The Phenomenology of the golfers' Yips, a Video-Panel Study.

Movement disorders clinical practice·2026

HD-DRUM Rhythmic Training in Huntington's Disease: Feasibility, Motor, and Brain Microstructural Pilot Signals.

Movement disorders clinical practice·2026

Nonpharmacological Interventions in Degenerative Cerebellar Ataxia: A Systematic Review.

Movement disorders clinical practice·2026

When Tics and Autism Meet: Phenomenology, Severity, and Treatment Patterns.

Movement disorders clinical practice·2026

DNA Methylation Profiling of rAAVs Reveals Hypomethylated Genomes and Evidence for Predominant Packaging of Replicated Genomes.

Viruses·2026

Evaluation of Anti-HIV-1 HSPC-Based Gene Therapy with Negative Selection Marker in Pigtail Macaques.

Viruses·2026

Host Barriers to In Vivo HSC Gene Therapy with Helper-Dependent Adenovirus Vectors.

Viruses·2026

Selecting Administration Routes for Therapeutic Extracellular Vesicles to Achieve Optimal Drug Delivery.

Molecules (Basel, Switzerland)·2026

c-Myc Links TGF-β Signaling to Metabolic Control of HIV Reactivation in OM10.1 Cells.

Microorganisms·2026

Host Protein Palmitoylation: A Two-Edged Sword in the Pathogenesis of COVID-19.

Microorganisms·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us